1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Conservative treatment of 29 patients with incomplete central retinal artery occlusion
Pentoxifyllin Hemodilution Aspirin Acetacolamid (Diamox) Heparin 2* (7.89%) 25† (86.2%) 4 (13.79%) 3 (10.34%) 10 (34.48%) Additional treatment or single treatment Pentoxifyllin + additional treatment in one patient* Hemodilution + additional treatment in 12 patients† 9 Heparin + 1 Marcumar) Pentoxifyllin only in one (3.45%) patient Hemodilution only in 11 (39.93%) patients Aspirin only in one (3.45%) patient Diamox only in one (3.45%) patient Heparin only in one (3.45%) patient
Note.—In all patients, an immediate massage of the globe and treatment of high blood pressure were performed.
* Pentoxifyllin + hemodilution + aspirin, one (3.45%) patient.
† Hemodilution + heparin, nine (31.03%) patients; hemodilution + aspirin, two (6.89%) patients; hemodilution + Diamox, two (6.89%) patients.